CoQ10 beat taurine on muscle-damage markers

Blocks of intensified training crowd matches and hard sessions together, and in young footballers that pattern is associated with more oxidative stress, muscle damage, inflammation and suppressed immune markers. Plenty of supplements are marketed as countermeasures, but direct head-to-head comparisons between them are scarce, so coaches and players are usually choosing on theory rather than on data. Coenzyme Q10 and taurine are two of the most commonly promoted options, with different proposed roles. This trial set out to test which of the two better blunts the biochemical stress of repeated match play in adolescent players.

The study was a randomised, double-blind, placebo-controlled comparative trial in 24 male under-19 soccer players with a mean age of 17.9 ± 0.7 years. Players were allocated to placebo (n = 8), CoQ10 at 300 mg/day (n = 8), or taurine at 4 g/day plus a further 4 g before each session (n = 8) for 14 days. All players completed three repeated 90-minute Soccer Match Simulation sessions. Blood was drawn at baseline, after the first session, after the third session, and 24 hours later, and analysed for creatine kinase, lactate dehydrogenase, malondialdehyde, total antioxidant capacity, IL-6, IL-10, TNF-α, cortisol, testosterone, the CD4/CD8 ratio, IgA, IgG and plasma volume, with two-way repeated-measures ANOVA.

CoQ10 came out ahead on the oxidative and catabolic markers: after the third session malondialdehyde was 0.83 ± 0.02 versus 1.24 ± 0.03 μmol/L, lactate dehydrogenase 434 ± 9 versus 684 ± 12 U/L, and cortisol 20.2 ± 0.6 versus 30.4 ± 0.8 μg/dL, with the testosterone:cortisol ratio better preserved (24.5 ± 1.1 versus 13.6 ± 1.0 × 10-3). CoQ10 also lowered IL-6 more than taurine (3.5 ± 0.2 versus 3.9 ± 0.2 pg/mL), whereas taurine raised IL-10 more (7.5 ± 0.2 versus 5.7 ± 0.2 pg/mL). Both supplements preserved CD4 counts (790 ± 13 and 795 ± 14 versus 680 ± 15 cells/μL in placebo) and the CD4/CD8 ratio, plus IgA and IgG, with no significant differences between the two supplements on any immune outcome. No adverse events were reported.

This is one of the first direct comparisons of two nutritional countermeasures in the same intensified-training model, rather than another supplement-versus-placebo study. It is consistent with the broad idea that antioxidant and amino-acid supplements can shift circulating stress markers, while adding the useful nuance that they do not act on the same markers. What it cannot say is whether any of these biochemical differences translate into better repeated-sprint performance, faster recovery between matches, or fewer illnesses — none of those outcomes were measured. It also leaves open the long-standing question of whether blunting oxidative signalling affects training adaptation over a season.

The reasonable reading is that CoQ10 and taurine are not interchangeable: in this small trial they moved different parts of the stress response, CoQ10 the oxidative-damage and cortisol markers, taurine the anti-inflammatory IL-10 signal. It is a reason to be sceptical of blanket claims that any one antioxidant is the recovery supplement for congested fixture periods. It is not evidence that either product makes players run faster, feel fresher, or get ill less often, because the study did not look. With eight players per arm, treat this as a signal that deserves a bigger trial rather than a settled comparison.